Treatment with Upadacitinib in Active Psoriatic Arthritis: Efficacy and Safety Data of the First 192 Patients from the UPJOINT Study, a Multicentre, Observational Study in Clinical Practice

INTRODUCTION: Our aim was to investigate the efficacy and safety of upadacitinib (UPA) in patients with either oligo- or polyarticular active psoriatic arthritis (PsA) using routine clinical practice data from an observational, prospective, multicentre study. METHODS: This interim analysis contains...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner, Stephanie G., Baraliakos, Xenofon, Reckert, Sabine, Bohl-Bühler, Martin, Laliberté, Marie-Claude, Girard, Tanya, Jeromin, Katharina, Baschuk, Nikola, Fritz, Björn, Bessette, Louis, Hueber, Axel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654267/
https://www.ncbi.nlm.nih.gov/pubmed/37695506
http://dx.doi.org/10.1007/s40744-023-00589-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654267/
https://www.ncbi.nlm.nih.gov/pubmed/37695506
http://dx.doi.org/10.1007/s40744-023-00589-3

Ejemplares similares